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The primary structure of human platelet profilin was determined by aligning the sequences of its tryptic peptides to the 
previously determined calf spleen profilin sequence [(1979) FEBS Lett. 101, 161L165]. Comparison of the peptide finger- 
prints of the two proteins suggested a higher homology than that found by direct sequence comparison. We therefore 
reinvestigated the sequences of the peptides from calf spleen profilin. We identified four incorrect charge assignments 
and a deletion of three residues. The similarity between the two vertebrate profilins amounts to 95%. 
Profilin; Amino acid sequence; (Calf spleen, Human platelet) 
1. INTRODUCTION 
The small actin-binding protein, profilin, has 
been isolated from a variety of sources including 
different mammalian non-muscle tissues or cell 
types [l-7], echinoderms [8,9], Physarum [lo] and 
Acanthamoeba [11,121. It inhibits the polymeriza- 
tion of actin and is therefore thought to function 
as an actin sequestering protein in vivo [ 1,13,14]. 
For Acanthamoeba nd sea urchin egg profilin, an 
additional capping activity of the barbed end of ac- 
tin filaments has been suggested [9,15]. In resting 
platelets, actin seems to exist primarily in the un- 
polymerized form in complex with profilin [ 13,161. 
During stimulation with thrombin 50-60% of this 
unpolymerized form is rapidly r-ecruited for fila- 
ment formation [ 17-201 a process which is accom- 
panied by changes in the interaction between 
profilin and actin [16,21]. Recently, it has been 
shown that phosphatidylinositol 4,5-bisphosphate 
by binding to profilin causes the dissociation of the 
profilin-actin complex [22] suggesting that agonist- 
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activated turnover in the phosphatidylinositol 
cycle somehow may be coupled to the recruitment 
of actin for polymerization. Phosphatidylinositol 
4,5-bisphosphate has also been shown to interact 
with gelsolin [23]. During the early phase of 
platelet activation gelsolin is activated from an in- 
active, non-actin interacting form, to a form which 
is complexed with actin [21,24]. This suggests the 
presence of actin and phospholipid interaction 
sites of regulatory importance in both proteins. 
So far, only the calf spleen profilin and the three 
isoforms of Acanthamoeba profilin have been se- 
quenced [25-271. Based on the limited similarity 
between these two profilins, the NHz-terminal 
region (residues l-35) was proposed to contain an 
actin-binding domain [26]. Recently, we also no- 
ticed that the COOH-terminal part of Acantha- 
moeba profilin contained a stretch of 16 amino 
acids (residues 104-119) displaying a high simila- 
rity with an internal sequence of the barbed end 
capping proteins, Physarum cap42(a) and human 
gelsolin (residues 94-109) [28]. Therefore, we pro- 
posed that Acanthamoeba profilin might have two 
actin-binding domains. First, a sequestering do- 
main located in the NHz-terminal part, shared with 
calf spleen profilin, and second, a capping domain 
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in the COOH-terminal part, in common with the 
barbed end capping proteins. Calf spleen profilin 
does not contain such a similar sequence and it 
might not have a capping activity. 
Human platelet profilin exhibits a chromato- 
graphic behaviour on phosphocellulose which is 
different from that of calf spleen profilin (un- 
published). In view of this difference and of the 
restricted sequence similarity seen between gelsolin 
and Acunthamoeba profilin as mentioned above, 
the question arose whether human platelet profilin 
might be more similar to the Acanthamoeba pro- 
filin than profilin from calf spleen. We therefore 
performed a comparative sequence analysis of the 
two mammalian profilins. During this work we en- 
countered possible errors in the sequence originally 
proposed for calf spleen profilin [25], which are 
reported here. From the final sequence comparison 
it is clear that the two mammalian profilins are 
closely similar. 
2. MATERIALS AND METHODS 
Human platelet profilin and calf spleen profilin were purified 
as described in [1,2]. The proteins were oxidized with performic 
acid [29] and subsequently dialyzed three times against water 
and once against NHdHCOp. Human platelet profilin (2 mg) 
and calf spleen profihn (3 mg) were cleaved with trypsin 
(Sigma) for 2 h at 37°C with an enzyme to substrate ratio of 
1: 50. The reaction was stopped by freeze-drying. Peptides were 
dissolved in pH 6.5 buffer (10% pyridine, 0.5% acetic acid) and 
separated with a two-dimensional technique on paper as 
described (e.g. [26]). Trp-containing peptides were identified by 
their fluorescence after performic acid oxidation. Peptides were 
detected with a dilute fluorescamine stain [30] and eluted with 
pH 6.5 buffer. 
The blocked NHr-terminal tryptic peptides of both profilins 
were further cleaved with chymotrypsin (Sigma) using the same 
conditions as for trypsin. The resulting subpeptides were 
purified as described above. 
Non-oxidized human platelet profilin (0.5 mg) was treated 
with 2-(2-nitrophenylsulfenyl)-3-methyl-3’-bromoindolenine 
(BNPS-skatole) according to Fontana [31]. The reaction mix- 
ture was dried and the excess reagent was removed with a mix- 
ture of acetone/acetic acid/triethylamine/water (17 : 1: 1: 1, by 
vol.). The remaining precipitate was extracted with pH 6.5 buf- 
fer and the soluble peptide was subjected to sequence deter- 
mination (see below). 
One third of each peptide was taken for standard acid 
hydrolysis and analyzed with a Biotronik ammo acid analyzer 
equipped with a fluorescence detector measuring the O- 
phthaldialdehyde r action products [32]; as a result, proline was 
not detected. This amino acid was identified in the course of the 
sequence determination. 
Another third of each peptide was subjected to sequence 
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determination using a gas-phase protein sequencer (Applied 
Biosystems, Inc.) operated according to Hewick et al. [33]. 
Stepwise liberated phenylthiohydantoin (PTH) amino acids 
were identified as described 134) and the amount was measured 
using an integrative recorder. Gaps were encountered where 
cysteic acid was present in the sequence but this amino acid 
could be assigned by subtraction of the peptide sequence from 
the composition. 
Prefixes P and S are given to distinguish the human platelet 
and calf spleen profilin peptides, respectively; T designates the 
trypsin peptides, and C the chymotrypsin subpeptides derived 
from the NHz-terminal tryptic peptides. Peptides are numbered 
according to their order in the sequence. Calf spleen profilin has 
one lysine and consequently one tryptic peptide less than human 
platelet profilin. The number of this peptide has been left out 
in the calf spleen profilin peptide numbering. Peptides starting 
at the same position, but having a different COOH-terminal 
residue are designated by a suffix a, for the shorter, and b, for 
the longer peptide. 
3. RESULTS AND DISCUSSION 
Amino acid sequence determination of intact 
human platelet profilin failed to reveal PTH- 
amino acids, indicating that the protein was 
NHz-terminally blocked. The nature of the block- 
ing group was not investigated here, but is assumed 
to be an acetyl group as is the case for calf spleen 
profilin [25]. 
To determine the sequence, tryptic peptides 
from the performic acid-oxidized protein were 
generated. These peptides were separated by a 
combination of paper electrophoresis and 
chromatography. In a parallel experiment, the 
tryptic peptides of performic acid-oxidized calf 
spleen profilin were purified. A comparison of the 
two fingerprints shows that both proteins are very 
similar (fig.1). Only three peptides move different- 
ly (T3, T9, and T12) and human platelet profilin 
contains one peptide more (TlO). All platelet pep- 
tides were characterized by their amino acid com- 
position (not shown) and, except for the blocked 
peptide Tl, by their full-length sequence. To verify 
the sequence at the blocked NHz-terminus, the cor- 
responding peptide was cleaved with chymotrypsin 
and the subpeptides were purified using elec- 
trophoresis at pH 6.5 (not shown). Two peptides 
were obtained. The Trp-containing peptide was 
still blocked while the longer one could be se- 
quenced (fig.2). From the sequence of the soluble 
Trp cleavage fragment (see section 2) and the com- 
position of the blocked NHz-terminal peptide, we 
can deduce the NHz-terminal sequence of profilin 
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Fig.1. Two-dimensional separation on paper of the tryptic 
peptides of human platelet (A) and calf spleen profilin (B). 
High-voltage electrophoresis was carried out in the horizontal 
direction; at either pH 6.5 (left, acidic and basic peptides) or pH 
3.5 (right, neutral peptides). Chromatography was carried out 
in vertical direction. (+) Anode; (-) cathode; 0, origin; O.G. 
and PYR, dye markers Orange G and pyronin, respectively. 
as shown in fig.2. Similarity with the calf spleen 
profilin was sufficiently high so that the platelet 
profilin peptides could be readily aligned. 
The soluble Trp cleavage fragment spanning 
region 4 to 31 showed one difference with the cor- 
responding region in the previously published calf 
spleen profilin. At position 10 Asp was found in- 
stead of Asn. The same difference was found in 
TlC2. Peptides PT2, PT4, PT6, PT8, PT14 and 
PT15 were completely identical to their calf spleen 
profilin analogues, whereas peptides PT3, PTS, 
PT7, PT12, and PT13a and b were different from 
the published calf spleen counterparts. The addi- 
tional peptide found in the human platelet profilin 
peptide map is due to the presence of lysine at posi- 
tion 104, generating the peptides PT9 and PTlO, 
instead of ST9 as found in calf spleen profilin. 
Peptide PTl 1 appeared to be three residues horter 
than STll. 
At this point our data disagree with the 
previously published sequence of calf spleen pro- 
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Fig.2. The amino acid sequence of calf spleen (CSP) and human 
platelet profilin (HPP). The platelet profilin peptides were 
characterized by their full-length sequence (full lines) except 
those containing a blocked NHz-terminus (broken lines). W 
denotes the soluble tryptophan cleavage product. Differences 
between the two proteins are found at positions 49, 59, 84, 100, 
104, 106 and 122. Residues denoted with an asterisk indicate the 
corrections made with regard to the calf spleen profilin 
sequence proposed in [25] (see text). The order of the first two 
amino acids in platelet profilin was not determined. These 
residues are positioned on the basis of the homology with spleen 
profilin and are shown between brackets. 
filin [25]. The spleen profilin peptides STl, STS, 
STll, ST12, and ST13a and b moved to similar 
positions during electrophoresis as their platelet 
profilin analogues. The electrophoretic mobility of 
these peptides, calculated according to Offord 
[35], differs from those predicted from the 
published sequence [25] (table 1). Also, if peptide 
ST11 contained the Asn-Gly-Glu sequence, then 
this should have markedly increased the retention 
during chromatography. Therefore, the sequence 
of these calf spleen profilin peptides was 
reinvestigated. Peptide STlC2, generated and 
purified in a similar way to PTlC2, contained Asp 
at cycle 7 instead of Asn. At this point it should be 
19 
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Table 1 
Calculated charge of the basic and acidic tryptic profilin 
peptides at pH 6.5 
Peptide Position in Calculated Predicted from 
the sequence 
This work ]251 
Tl l- 25 -3.10 -4 -3 
T5 56- 69 +0.80 +I 0 
T7 7% 98 -3.04 -3 -3 
T8 89- 90 +0.94 +1 +1 
PT9 91-104 +1.04 +1 +1 
ST9 91-107 +1.01 +l +1 
Tll 108-115 +0.95 +1 0 
T12 116-126 + 1.70 + 1.5 +2.5 
T13a 127-135 - 0.40 -0.5 +0.5 
T13b 127-136 + 0.55 +0.5 + 1.5 
T14 136-139 +I.18 +I +1 
The charges were calculated by regression analysis using the 
relative mobilities determined according to Offord [35]. For 
cysteic acid and internal histidine a net charge of - 1 and + 0.5 
was given, respectively 
noted that Asn-Gly sequences are known to 
deamidate readily through hydrolysis of a cyclic 
imide’ formed in basic conditions and resulting in 
a mixture of cz-aspartylglycine and ,B-aspartyl- 
glycine sequences 1361. Such a situation yields a 
mixture of Asp and Asn and reduces abnormally 
the repetitive yield of the Edman degradation at 
the position of the deamidated residue. 
A quantitative estimation of the phenyl- 
thiohydantoin amino acid derivatives generated at 
positions 6, 7 and 8 during sequence analysis of 
peptide STlC2 yielded 11.7, 9.9 and 8.1 pmol of 
the derivatives of Ala, Asp and Gly, respectively. 
In addition, no PTH-Asn was observed at position 
7. We are therefore confident that the observed 
Asp at position 13 of the calf spleen profilin se- 
quence is a true Asp residue rather than being 
derived by deamidation of an original Asn residue, 
as a comparison with the previously published se- 
quence [25] might suggest. 
Peptide ST5 had Gln instead of Glu at cycle 13 
and peptides ST12, ST13a and b, contained Glu in- 
stead of Gln, at the first and third degradation cy- 
cle, respectively. These data are now in agreement 
with the calculated net-charges (table 1). Peptide 
ST11 was indeed three residues shorter than 
originally reported, consistent with its composition 
and its mobility in the chromatogram (table 1). All 
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other tryptic calf spleen profilin peptides were se- 
quenced but showed no difference with the 
previously published sequence. Thus, five correc- 
tions are proposed in the calf spleen profilin se- 
quence as published previously. At positions 13, 
68, 116 and 129, one should read Asp, Gln, Glu 
and Glu, instead of Asn, Glu, Gln, and Gln, 
respectively, and the tripeptide Asn-Gly-Glu 
(previously positions 113- 115) should be deleted. 
Calf spleen profilin is thus three residues horter 
than originally reported and both profilins contain 
139 amino aids. The true differences between calf 
spleen and human platelet profilin are then found 
at positions 49 (Ile-Val), 59 (Phe-Tyr), 84 (Thr- 
Ser), 100 (Ile-Val), 104 (Met-Lys), 106 (Ala-Asp), 
and 122 (Met-Leu) (fig.2). The similarity between 
the two proteins is thus 95%. Most of the dif- 
ferences found concern conservative amino acid 
exchanges, except at positions 104 (Met-Lys) and 
106 (Ala-Asp). Although the isoelectric point of 
both proteins will still be very similar these changes 
induce a drastic difference in the hydrophobicity 
pattern covering region 98-113 (fig.3). This 
hydrophobic region is interrupted by two 
hydrophilic residues in human platelet profilin. 
Here, three-dimensional structure analysis will 
provide information on the impact of these amino 
acid exchanges on the overall structure and even- 
tually on the actin interaction of both profilins. 
The corrections made here do not significantly 
increase the similarity with the Acanthamoeba pro- 
Fig.3. Comparison of the hydropathicity patterns of calf spleen 
profilin (A) and human platelet profilin (B). Profiles were 
calculated according to [38] using a span setting of 6 residues. 
Note the marked change in local hydropathy between residues 
100 and 110. 
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filins [26,27]. However, it should be noted that no 
mutation has been ,found within the NHz-terminal 
domain of the two vertebrate profilins. This region 
was proposed to participate in actin-binding, based 
on the limited similarity with Acanthamoeba pro- 
filin [26]. This region also remained very constant 
in the three Acanthamoeba profilin isoforms [27]. 
In the light of the possible similar active regula- 
tion mechanism of actin interaction with gelsolin 
or profilin in platelets [21] it is difficult to under- 
stand which sequence of both actin-binding pro- 
teins is involved. Indeed, no clear homologous 
region can be defined in the two proteins. The con- 
sensus sequence, as proposed by Burgoyne [37], 
found in gelsolin, p36 and ~35, and thought to be 
involved in actin or phospholipid interaction is not 
readily recognized in the vertebrate profilins. It 
will be interesting to learn from the three- 
dimensional structure which region of vertebrate 
profilin is involved in phospholipid binding and 
whether a similar domain is present in gelsolin. 
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